Cancer genomics firm Tempus' pact with Cleveland's UH Seidman Cancer Center adds to its list of partnerships with academic oncology centers.
As SpeeDx preps for the European launch of its STI tests, it will incorporate UgenTec's automated data analysis tool for PCR applications.
The company also extended its existing licensing agreement with Genalice, signed in 2013, to improve plant DNA analysis.
Objectives for this year include building a network of ELIXIR beacons, developing new features and security measures, and partnering with data owners.
Researchers applied their gene genealogy interrogation approach to fish in the otophysan clade before moving on to other branches in the tree of life.
The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.
The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.
The first Reproducibility Project: Cancer Biology papers show mixed results.
In Nature this week: mobile phone-based targeted DNA sequencing, and more.